Author response to Colle et al

von Fucà, Giovanni, Corti, Francesca, Pietrantonio, Filippo
Veröffentlicht in J Immunother Cancer (2021)

Continuing Single-Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First-Line Treatment of Metastatic Colorectal Cancer

von Díaz-Rubio, Eduardo, Pietrantonio, Filippo, de Braud, Filippo
Veröffentlicht 2012

LightSNiP assay is a good strategy for pharmacogenetics test

von Cheli, Stefania, Pietrantonio, Filippo, Clementi, Emilio, Falvella, Felicia S.
Veröffentlicht in Front Pharmacol (2015)

Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges

von Miceli, Rosalba, Tomasello, Gianluca, Bregni, Giacomo, Di Bartolomeo, Maria, Pietrantonio, Filippo
Veröffentlicht 2014

BRAF-mutated metastatic colorectal cancer between past and future

von Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Veröffentlicht in Br J Cancer (2015)

Targeting cancer metabolism: dietary and pharmacological interventions

von Vernieri, Claudio, Casola, Stefano, Foiani, Marco, Pietrantonio, Filippo, de Braud, Filippo, Longo, Valter
Veröffentlicht in Cancer Discov (2016)

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5- fluorouracil: a meta-analysis of published trials

von Iacovelli, Roberto, Pietrantonio, Filippo, Palazzo, Antonella, Maggi, Claudia, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Veröffentlicht in Br J Clin Pharmacol (2014)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

von Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Veröffentlicht in Clin Interv Aging (2015)

In Reply

von Baratti, Dario, Kusamura, Shigeki, Maggi, Claudia, de Braud, Filippo, Deraco, Marcello, Di Bartolomeo, Maria, Pietrantonio, Filippo
Veröffentlicht in Oncologist (2015)

Bax Expression Is Predictive of Favorable Clinical Outcome in Chemonaive Advanced Gastric Cancer Patients Treated with Capecitabine, Oxaliplatin, and Irinotecan Regimen

von Pietrantonio, Filippo, Biondani, Pamela, de Braud, Filippo, Pellegrinelli, Alessandro, Bianchini, Giampaolo, Perrone, Federica, Formisano, Barbara, Di Bartolomeo, Maria
Veröffentlicht 2012

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

von Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Veröffentlicht 2014

Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials

von Modest, Dominik Paul, Rivera, Fernando, Bachet, Jean‐Baptiste, de Braud, Filippo, Pietrantonio, Filippo, Koukakis, Reija, Demonty, Gaston, Douillard, Jean‐Yves
Veröffentlicht in Int J Cancer (2019)

The Landscape of Actionable Gene Fusions in Colorectal Cancer

von Pagani, Filippo, Randon, Giovanni, Guarini, Vincenzo, Raimondi, Alessandra, Prisciandaro, Michele, Lobefaro, Riccardo, Di Bartolomeo, Maria, Sozzi, Gabriella, de Braud, Filippo, Gasparini, Patrizia, Pietrantonio, Filippo
Veröffentlicht in Int J Mol Sci (2019)

Role of MGMT as biomarker in colorectal cancer

von Inno, Alessandro, Fanetti, Giuseppe, Di Bartolomeo, Maria, Gori, Stefania, Maggi, Claudia, Cirillo, Massimo, Iacovelli, Roberto, Nichetti, Federico, Martinetti, Antonia, de Braud, Filippo, Bossi, Ilaria, Pietrantonio, Filippo
Veröffentlicht in World J Clin Cases (2014)

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Med...

von Dieci, Maria Vittoria, Massari, Francesco, Giusti, Raffaele, Inno, Alessandro, Lombardi, Giuseppe, Noto, Laura, Passaro, Antonio, Pietrantonio, Filippo, Spada, Francesca, Valente, Monica, Di Maio, Massimo, Torri, Valter
Veröffentlicht in ESMO Open (2018)

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

von Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Veröffentlicht 2014

miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

von Migliore, Cristina, Morando, Elena, Ghiso, Elena, Anastasi, Sergio, Leoni, Vera P, Apicella, Maria, Cora', Davide, Sapino, Anna, Pietrantonio, Filippo, De Braud, Filippo, Columbano, Amedeo, Segatto, Oreste, Giordano, Silvia
Veröffentlicht in EMBO Mol Med (2018)

Practical considerations in the use of regorafenib in metastatic colorectal cancer

von Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Veröffentlicht in Ther Adv Med Oncol (2020)

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

von Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Veröffentlicht 2014

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

von Petrelli, Fausto, Berenato, Rosa, Turati, Luca, Mennitto, Alessia, Steccanella, Francesca, Caporale, Marta, Dallera, Pierpaolo, de Braud, Filippo, Pezzica, Ezio, Di Bartolomeo, Maria, Sgroi, Giovanni, Mazzaferro, Vincenzo, Pietrantonio, Filippo, Barni, Sandro
Veröffentlicht in J Gastrointest Oncol (2017)